Showing results (811-820 of 1,142) with videos related to
Sort By:
Pageof 115
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2012
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responsesFei Zhao, Bastian Hoechst, Jaba Gamrekelashvili, et al.The Lancet. Haematology|April 30, 2025
Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)Malgorzata Mikulska, Florian van Bömmel, Charlotte Mouliade, et al.Transplantation|December 10, 1999
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trialH Wedemeyer, K H Böker, K Pethig, et al.Alimentary Pharmacology & Therapeutics|August 8, 2015
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapiesK Deterding, C Höner Zu Siederdissen, K Port, et al.Plos One|August 1, 2015
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort StudyWolf Peter Hofmann, Stefan Mauss, Thomas Lutz, et al.Journal of Viral Hepatitis|May 18, 2021
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R)Valerie Ohlendorf, Arne Schäfer, Stefan Christensen, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2013
Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis deltaGökhan Kabaçam, Heiner Wedemeyer, Berna Savaş, et al.The Journal of Infectious Diseases|November 3, 2016
The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T CellsThomas Schirdewahn, Jan Grabowski, Solomon Owusu Sekyere, et al.Journal of Hepatology|November 10, 2012
Clinical management of drug-drug interactions in HCV therapy: challenges and solutionsDavid Burger, David Back, Peter Buggisch, et al.Alimentary Pharmacology & Therapeutics|November 10, 2022
Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosisTammo L Tergast, Benjamin Schulte, Marie Griemsmann, et al.Pageof 115